Iovance Biotherapeutics, Inc. (LON:0JDK)

Iovance Biotherapeutics Revenue

Iovance Biotherapeutics had revenue of $49.32M USD in the quarter ending March 31, 2025, with 6,798.46% growth. This brings the company's revenue in the last twelve months to $212.68M, up 11,070.12% year-over-year. In the year 2024, Iovance Biotherapeutics had annual revenue of $164.07M with 13,698.99% growth.

• Revenue (ttm): $212.68M
• Revenue Growth: +11,070.12%
• P/S Ratio: 2.81
• Revenue / Employee: $253.79K
• Employees: 838
• Market Cap: 462.61M GBP

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	164.07M	162.88M	13,698.99%
Dec 31, 2023	1.19M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	-	-	-